Charlene Stern

Charlene is the Executive Vice President and General Counsel of Editas Medicine, and she was part of the team that launched Editas Medicine in 2013. As General Counsel, she oversees and manages all legal matters, including corporate governance, securities compliance and SEC reporting, partnering and licensing transactions, financings, and intellectual property strategy. She also serves as Editas Medicines Corporate Secretary. Prior to Editas Medicine, Charlene was senior patent counsel at AVEO Oncology, where she was responsible for developing and executing AVEO's intellectual property strategy. Earlier in her career, she was a senior attorney in the Boston office of GoodWin LLP and a patent agent at Foley Hoag LLP. Before beginning her legal career, Charlene was an American Cancer Society post-doctoral fellow at Dana-Farber Cancer Institute.